Commercially Available Angiotensin II At2 Receptor Antibodies Are Nonspecific

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Hafko, Roman ^a   Villapol, Sonia ^b,c   Nostramo, Regina ^d   Symes, Aviva ^b,c   Sabban, Esther L ^d   Inagami, Tadashi ^e   Saavedra, Juan M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b Center for Neuroscience and Regenerative Medicine   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTIBODY; MESSENGER RNA; MONOCLONAL ANTIBODY AAR 012; POLYCLONAL ANTIBODY 2818 1; POLYCLONAL ANTIBODY SC 9040; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; BINDING AFFINITY; CHEMICAL ANALYSIS; CONTROLLED STUDY; EPENDYMA CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIGAND BINDING; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ZONA GLOMERULOSA;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; BRAIN; BRAIN CHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER;

MUS; RATTUS;

EID: 84879742771     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069234     Document Type: Article

References (67)

1. Bader M, (2010) Tissue renin-Angiotensin-aldosterone systems: targets for pharmacological therapy. Annu Rev Pharmacol Toxicol 50: 439-465. doi:10.1146/annurev.pharmtox.010909.105610. PubMed: 20055710.
2. Paul M, Poyan Mehr A, Kreutz R, (2006) Physiology of local renin-angiotensin systems. Physiol Rev 86: 747-803. doi:10.1152/physrev.00036.2005. PubMed: 16816138.
3. Saavedra JM, Sánchez-Lemus E, Benicky J, (2011) Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications. Psychoneuroendocrinology 36: 1-18. doi:10.1016/j.psyneuen.2010.10.001. PubMed: 21035950.
4. Saavedra JM, (2012) Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders. Clin Sci (Lond) 123: 567-590. doi:10.1042/CS20120078. PubMed: 22827472.
5. Mehta PK, Griendling KK, (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82-C97. PubMed: 16870827.
6. Savoia C, Schiffrin EL, (2007) Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci 112: 375-384.
7. Skrbic R, Igic R, (2009) Seven decades of Angiotensin (1939-2009). Peptides 30: 1945-1950. doi:10.1016/j.peptides.2009.07.003. PubMed: 19595728.
8. Padia SH, Carey RM, (2013) AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function. Pflugers Arch 465: 99-110. doi:10.1007/s00424-012-1146-3. PubMed: 22949090.
9. Rompe F, Unger T, Steckelings UM, (2010) The angiotensin AT2 receptor in inflammation. Drug News Perspect 23: 104-111. doi:10.1358/dnp.2010.23.2.1475901. PubMed: 20369075.
10. McCarthy CA, Vinh A, Callaway JK, Widdop RE, (2009) Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. Stroke 40: 1482-1489. doi:10.1161/STROKEAHA.108.531509. PubMed: 19246705.
11. Steckelings UM, Unger T, (2012) Angiotensin II type 2 receptor agonists--where should they be applied? Expert Opin Investig Drugs 21: 763-766. doi:10.1517/13543784.2012.681046. PubMed: 22519550.
12. Verdonk K, Danser AH, van Esch JH, (2012) Angiotensin II type 2 receptor agonists: where should they be applied? Expert Opin Investig Drugs 21: 501-513. doi:10.1517/13543784.2012.664131. PubMed: 22348403.
13. Armando I, Terrón JA, Falcón-Neri A, Takeshi I, Häuser W, et al. (2002) Increased angiotensin II AT(1) receptor expression in paraventricular nucleus and hypothalamic-pituitary-adrenal axis stimulation in AT(2) receptor gene disrupted mice. Neuroendocrinology 76: 137-147. doi:10.1159/000064525. PubMed: 12218346.
14. Pavel J, Terrón JA, Benicky J, Falcón-Neri A, Rachakonda A, et al. (2009) Increased angiotensin II AT1 receptor mRNA and binding in spleen and lung of AT2 receptor gene disrupted mice. Regul Pept 158: 156-166. doi:10.1016/j.regpep.2009.09.004. PubMed: 19766151.
15. Saavedra JM, Häuser W, Ciuffo G, Egidy G, Hoe KL, et al. (2001) Increased AT(1) receptor expression and mRNA in kidney glomeruli of AT(2) receptor gene-disrupted mice. Am J Physiol Renal Physiol 280: F71-F78. PubMed: 11133516.
16. Saavedra JM, Armando I, Terrón JA, Falcón-Neri A, Jöhren O, et al. (2001) Increased AT(1) receptors in adrenal gland of AT(2) receptor gene-disrupted mice. Regul Pept 102: 41-47. doi:10.1016/S0167-0115(01)00303-2. PubMed: 11600209.
17. Siragy HM, (2009) The potential role of the angiotensin subtype 2 receptor in cardiovascular protection. Curr Hypertens Rep 1: 260-262.
18. de Gasparo M, Siragy HM, (1999) The AT2 receptor: fact, fancy and fantasy. Regul Pept 81: 11-24. doi:10.1016/S0167-0115(99)00023-3. PubMed: 10395404.
19. Allen AM, Zhuo J, Mendelsohn FA, (1999) Localization of angiotensin AT1 and AT2 receptors. J Am Soc Nephrol 10 (Suppl 11):: S23-S29. PubMed: 9892137.
20. Saavedra JM, (2005) Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol Neurobiol 25: 485-512. doi:10.1007/s10571-005-4011-5. PubMed: 16075377.
21. Porrello ER, Delbridge LM, Thomas WG, (2009) The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor. Front Biosci 14: 958-972. PubMed: 19273111.
22. Saper CB, Sawchenko PE, (2003) Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry. J Comp Neurol 465: 161-163. doi:10.1002/cne.10858. PubMed: 12949777.
23. Saper CB, (2005) An open letter to our readers on the use of antibodies. J Comp Neurol 493: 477-478. doi:10.1002/cne.20839. PubMed: 16304632.
24. Saper CB, (2009) A guide to the perplexed on the specificity of antibodies. J Histochem Cytochem 57: 1-5. PubMed: 18854594.
25. Rhodes KJ, Trimmer JS, (2006) Antibodies as valuable neuroscience research tools versus reagents of mass distraction. J Neurosci 26: 8017-8020. doi:10.1523/JNEUROSCI.2728-06.2006. PubMed: 16885215.
26. Lorincz A, Nusser Z, (2008) Specificity of immunoreactions: the importance of testing specificity in each method. J Neurosci 28: 9083-9086. doi:10.1523/JNEUROSCI.2494-08.2008. PubMed: 18784286.
27. Michel MC, Wieland T, Tsujimoto G, (2009) How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch Pharmacol 379: 385-388. doi:10.1007/s00210-009-0395-y. PubMed: 19172248.
28. Benicky J, Hafko R, Sanchez-Lemus E, Aguilera G, Saavedra JM, (2012) Six commercially available angiotensin II AT(1) receptor antibodies are non-specific Cell Mol Neurobiol 32: 1353-1365. doi:10.1007/s10571-012-9862-y. PubMed: 22843099.
29. Herrera M, Sparks MA, Alfonso-Pecchio AR, Harrison-Bernard LM, Coffman TM, (2013) Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein. Hypertension 61: 253-258. doi:10.1161/HYPERTENSIONAHA.112.203679. PubMed: 23150519.
30. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, et al. (1995) Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377: 748-750. doi:10.1038/377748a0. PubMed: 7477267.
31. Ichiki T, Inagami T, (1995) Expression, genomic organization, and transcription of the mouse angiotensin II type 2 receptor gene. Circ Res 76: 693-700. doi:10.1161/01.RES.76.5.693. PubMed: 7728985.
32. Inagami T, Iwai N, Sasaki K, Yamano Y, Bardhan S, et al. (1994) Cloning, expression and regulation of angiotensin II receptors. Eur Heart J Suppl D: pp. 104-107.
33. Tsutsumi K, Saavedra JM, (1991) Characterization and development of Angiotensin II receptor subtypes (AT1 and AT2) in rat brain. Am J Physiol 261: R209-R216. PubMed: 1858948.
34. Pucell AG, Hodges JC, Sen I, Bumpus FM, Husain A, (1991) Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor. Endocrinology 128: 1947-1959. doi:10.1210/endo-128-4-1947. PubMed: 1848506.
35. Lazard D, Villageois P, Briend-Sutren MM, Cavaillé F, Bottari S, et al. (1994) Characterization of a membrane glycoprotein having pharmacological and biochemical properties of an AT2 angiotensin II receptor from human myometrium. Eur J Biochem 220: 919-926. doi:10.1111/j.1432-1033.1994.tb18695.x. PubMed: 8143746.
36. Yee DK, Reagan LP, Moga CN, Siemens IR, Fluharty SJ, (1994) Angiotensin II stabilizes a multimeric type 2 (AT2) receptor complex in murine neuroblastoma N1E-115 cells. Regul Pept 54: 355-366. doi:10.1016/0167-0115(94)90533-9. PubMed: 7716270.
37. Servant G, Dudley DT, Escher E, Guillemette G, (1994) The marked disparity between the sizes of angiotensin type 2 receptors from different tissues is related to different degrees of N-glycosylation. Mol Pharmacol 45: 1112-1118. PubMed: 8022404.
38. Aguilera G, Kapur S, Feuillan P, Sunar-Akbasak B, Bathia AJ, (1994) Developmental changes in angiotensin II receptor subtypes and AT1 receptor mRNA in rat kidney. Kidney Int 46: 973-979. doi:10.1038/ki.1994.356. PubMed: 7861723.
39. Baiardi G, Macova M, Armando I, Ando H, Tyurmin D, et al. (2005) Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat. Regul Pept 124: 7-17. doi:10.1016/j.regpep.2004.06.021. PubMed: 15544836.
40. Gibson RE, Thorpe HH, Cartwright ME, Frank JD, Schorn TW, et al. (1991) Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys. Am J Physiol 261: F512-F518. PubMed: 1653532.
41. Griffin CA, Giacchetti G, Schambelan M, Sechi LA, (1997) Ontogenic expression of renal and hepatic angiotensin II receptor genes in the rat. Nephron 76: 103-110. doi:10.1159/000190148. PubMed: 9171308.
42. Häuser W, Jöhren O, Saavedra JM, (1998) Characterization and distribution of Angiotensin II receptor subtypes in the mouse brain. Eur J Pharmacol 348: 101-114. PubMed: 9650837.
43. Heemskerk FM, Saavedra JM, (1995) Quantitative autoradiography of angiotensin II AT2 receptors with [125I]CGP 42112. Brain Res 677: 29-38. doi:10.1016/0006-8993(95)00092-5. PubMed: 7606467.
44. Jöhren O, Inagami T, Saavedra JM, (1996) Localization of AT2 angiotensin II receptor gene expression in rat brain by in situ hybridization histochemistry. Brain Res Mol Brain Res 37: 192-200. doi:10.1016/0169-328X(95)00309-G. PubMed: 8738151.
45. Jöhren O, Golsch C, Dendorfer A, Qadri F, Häuser W, et al. (2003) Differential expression of AT1 receptors in the pituitary and adrenal gland of SHR and WKY. Hypertension 41: 984-990. doi:10.1161/01.HYP.0000062466.38314.B7. PubMed: 12642505.
46. Kakuchi J, Ichiki T, Kiyama S, Hogan BL, Fogo A, et al. (1995) Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int 47: 140-147. doi:10.1038/ki.1995.16. PubMed: 7731139.
47. Lenkei Z, Palkovits M, Corvol P, Llorens-Cortès C, (1997) Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol 18: 383-439. doi:10.1006/frne.1997.0155. PubMed: 9344632.
48. Sanvitto GL, Jöhren O, Häuser W, Saavedra JM, (1997) Water deprivation upregulates ANG II AT1 binding and mRNA in rat subfornical organ and anterior pituitary. Am J Physiol 273: E156-E163. PubMed: 9252492.
49. Shanmugam S, Corvol P, Gasc JM, (1996) Angiotensin II type 2 receptor mRNA expression in the developing cardiopulmonary system of the rat. Hypertension 28: 91-97. doi:10.1161/01.HYP.28.1.91. PubMed: 8675270.
50. Shanmugam S, Llorens-Cortes C, Clauser E, Corvol P, Gasc JM, (1995) Expression of angiotensin II AT2 receptor mRNA during development of rat kidney and adrenal gland. Am J Physiol 268: F922-F930. PubMed: 7771520.
51. Seltzer A, Pinto JE, Viglione PN, Correa FM, Libertun C, et al. (1992) Estrogens regulate angiotensin-converting enzyme and angiotensin receptors in female rat anterior pituitary. Neuroendocrinology 55: 460-467. doi:10.1159/000126157. PubMed: 1314339.
52. Tsutsumi K, Saavedra JM, (1991) Angiotensin-II receptor subtypes in median eminence and basal forebrain areas involved in regulation of pituitary function Endocrinology 129: 3001-3008. doi:10.1210/endo-129-6-3001. PubMed: 1954884.
53. Tsutsumi K, Strömberg C, Saavedra JM, (1992) Characterization of angiotensin II receptor subtypes in the rat spleen. Peptides 13: 291-296. doi:10.1016/0196-9781(92)90111-F. PubMed: 1329044.
54. Zhuo J, Song K, Harris PJ, Mendelsohn FA, (1992) In vitro autoradiography reveals predominantly AT1 angiotensin II receptors in rat kidney. Ren Physiol Biochem 15: 231-239. PubMed: 1279763.
55. Armando I, Jezova M, Juorio AV, Terrón JA, Falcón-Neri A, et al. (2002) Estrogen upregulates renal angiotensin II AT(2) receptors. Am J Physiol Renal Physiol 283: F934-F943. PubMed: 12372768.
56. Ciuffo GM, Viswanathan M, Seltzer AM, Tsutsumi K, Saavedra JM, (1993) Glomerular angiotensin II receptor subtypes during development of rat kidney. Am J Physiol 265: F264-F271. PubMed: 8368335.
57. Correa FM, Viswanathan M, Ciuffo GM, Tsutsumi K, Saavedra JM, (1995) Kidney angiotensin II receptors and converting enzyme in neonatal and adult Wistar-Kyoto and spontaneously hypertensive rats. Peptides 16: 19-24. doi:10.1016/0196-9781(94)00150-5. PubMed: 7716070.
58. Tsutsumi K, Strömberg C, Viswanathan M, Saavedra JM, (1991) Angiotensin-II receptor subtypes in fetal tissue of the rat: autoradiography, guanine nucleotide sensitivity, and association with phosphoinositide hydrolysis. Endocrinology 129: 1075-1082. doi:10.1210/endo-129-2-1075. PubMed: 1649738.
59. Hunley TE, Tamura M, Stoneking BJ, Nishimura H, Ichiki T, et al. (2000) The angiotensin type II receptor tonically inhibits angiotensin- converting enzyme in AT2 null mutant mice. Kidney Int 57: 570-577. doi:10.1046/j.1523-1755.2000.00877.x. PubMed: 10652034.
60. Rateri DL, Moorleghen JJ, Balakrishnan A, Owens AP 3rd, Howatt DA, et al. (2011) Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/- mice. Circ Res 108: 574-581. doi:10.1161/CIRCRESAHA.110.222844. PubMed: 21252156.
61. Elliott KJ, Kimura K, Eguchi S, (2013) Lack of specificity of commercial antibodies leads to misidentification of angiotensin type-1 receptor protein. Hypertension 61: e31. doi:10.1161/HYPERTENSIONAHA.111.00943. PubMed: 23381793.
62. Jositsch G, Papadakis T, Haberberger RV, Wolff M, Wess J, et al. (2009) Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 379: 389-395. doi:10.1007/s00210-008-0365-9. PubMed: 18974978.
63. Jensen BC, Swigart PM, Simpson PC, (2009) Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific. Naunyn Schmiedebergs Arch Pharmacol 379: 409-412. doi:10.1007/s00210-008-0368-6. PubMed: 18989658.
64. Bodei S, Arrighi N, Spano P, Sigala S, (2009) Should we be cautious on the use of commercially available antibodies to dopamine receptors? Naunyn Schmiedebergs Arch Pharmacol 379: 413-415. doi:10.1007/s00210-008-0384-6. PubMed: 19096766.
65. Hamdani N, van der Velden J, (2009) Lack of specificity of antibodies directed against human beta-adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol 379: 403-407. doi:10.1007/s00210-009-0392-1. PubMed: 19156400.
66. Lu X, Bartfai T, (2009) Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice. Naunyn Schmiedebergs Arch Pharmacol 379: 417-420. doi:10.1007/s00210-009-0394-z. PubMed: 19159918.
67. Pradidarcheep W, Stallen J, Labruyère WT, Dabhoiwala NF, Michel MC, et al. (2009) Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol 379: 397-402. doi:10.1007/s00210-009-0393-0. PubMed: 19198807.